Houston, TX, United States of America

Eric M Eastman

This inventor holds 2 USPTO granted patents. Top assignee: Genemedicine, Inc.. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric M Eastman. Retrieved from https://idiyas.com/inventor/eric-m-eastman-s9q8rcls

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Eric M Eastman

Introduction

Eric M Eastman is an accomplished inventor based in Houston, TX (US). He has made significant contributions to the field of gene therapy, holding a total of 2 patents. His work focuses on developing plasmid constructs that are essential for nonviral human gene therapy.

Latest Patents

One of his latest patents is titled "Plasmid for delivery of nucleic acids to cells and methods of use." This invention relates to plasmid constructs that are useful for nonviral human gene therapy. The plasmid constructs incorporate elements that achieve a high copy number, avoid plasmid instability, and provide a plasmid selection process. These constructs can be utilized to deliver nucleic acids to cells in vehicles that are compatible with human therapeutic use.

Career Highlights

Eric M Eastman is currently associated with Genemedicine, Inc., where he continues to innovate in the field of gene therapy. His expertise and dedication to advancing medical technology have made him a valuable asset to his company.

Collaborations

Eric collaborates with Ross H Durland, contributing to the development of groundbreaking technologies in gene therapy.

Conclusion

Eric M Eastman is a notable inventor whose work in plasmid constructs is paving the way for advancements in nonviral human gene therapy. His contributions are significant in the ongoing evolution of medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…